Veracyte Inc
NASDAQ:VCYT

Watchlist Manager
Veracyte Inc Logo
Veracyte Inc
NASDAQ:VCYT
Watchlist
Price: 42.17 USD 2.6% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
Veracyte Inc?
Write Note

P/OCF
Price to OCF

49.4
Current
44.2
Median
21.6
Industry
Higher than median
Higher than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
49.4
=
Market Cap
3.3B USD
/
Operating Cash Flow
66.1m USD
All Countries
Close
Market Cap P/OCF
US
Veracyte Inc
NASDAQ:VCYT
3.3B USD 49.4
FR
Pharnext SCA
OTC:PNEXF
6T USD -238 693.4
US
Abbvie Inc
NYSE:ABBV
314.7B USD 19.1
US
Amgen Inc
NASDAQ:AMGN
147.4B USD 20.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD -141.7
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 11.4
US
Epizyme Inc
F:EPE
94.1B EUR -471.3
AU
CSL Ltd
ASX:CSL
135.4B AUD 31.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 19.5
US
Seagen Inc
F:SGT
39.3B EUR -76.1
NL
argenx SE
XBRU:ARGX
34.3B EUR -138.1

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More